RESULTS OF BACTERIOLOGICAL TESTS IN THOSE SUFFERING FROM PULMONARY MALICIOUS TUMORS DEPENDING ON THE PRESENCE OF COPD AND TECHNIQUE OF THE SAMPLE COLLECTION FROM THE RESPIRATORY TRACT

Goal of the study: to study the bacterial population in the respiratory tract at various levels in those suffering from pulmonary malicious tumors including patients with concurrent chronic obstructive pulmonary disease (COPD).

Materials and methods. Bacterial population of the respiratory tract was studied in two groups: Group 1 included 52 lung cancer patients without COPD, Group 2 included 23 lung cancer patients with concurrent COPD.

Results. In the lung cancer patients none of the technique of the sample collection from respiratory tract used by itself did not allow identification of the whole spectrum of bacterial population in the respiratory tract. The most comprehensive picture of bacterial population in the respiratory tract could be obtained through integral bacteriological testing of the smear out of pharynx, sputum, bronchial aspirate/washout and samples obtained through «protected» brush biopsy. The study of the bacterial population profile showed that Candida fungi prevail in the upper respiratory tract and the following gram-negative bacteria prevail in the lower respiratory tract: Citrobacter, Serratia, Acinetobacter, Pseudomonas, Escherichia, klebsiella, Enterobacter, Burkholderia. It was found out that the bacterial load in the respiratory tract in the lung cancer patients associated with COPD (115 strains in 23 patients) was significantly higher compared to one of those suffering from lung cancer only (108 strains in 52 patients).

1. Akopov A. Modern approaches to the lung cancer classification. Vrach, 2011, no. 12, pp. 7-12. (In Russ.)

2. Dmitrieva N.V., Diakova S.А., Ryabova N.V. Taksonomicheskaya struktura mikroorganizmov i antimikrobnaya chuvstvitelnost’, pokazateli 2009 g. Аntimikrobnye preparaty i standarty lecheniya infektsionnykh oslozhneniy u onkologicheskikh bolnykh. [Taxonomic structure of microorganisms and anti-microbial sensitivity, rates for 2009. Antimicrobial agents and treatment standards of infectious complications in cancer patients]. Moscow, Prakticheskaya Meditsina Publ., 2011, pp. 13-19.

3. Zubkov M.N. Biomaterialy pri infektsiyakh verkhnikh dykhatelnykh putey. Biomaterialy pri infektsiyakh nizhnikh dykhatelnykh putey. Klinicheskaya laboratornaya analitika v pyati tomakh. Chastnye analiticheskie tekhnologii v klinicheskoy laboratorii. [Biomaterials in infections of the upper respiratory tract. Biomaterials in infections of the lower respiratory tract. Clinical laboratory analytical materials, five volumes. Certain analytical technologies in the clinical laboratory]. Moscow, Agat-Med Publ., 2003, vol. IV, pp. 291-310.

4. Zubkov M.N. Collection, transportation of biological materials and interpretation of microbiological test results. Klin. Mikrobiologiya i Antimikrobnaya Khimioterapiya, 2004, vol. 6, no. 2, pp. 143-154. (In Russ.)

5. Labinskaya А.S., Drinyaev V.А., Berezkina E.N. Tekhnika poseva, kultivirovaniya i vydeleniya chistykh kultur mikroorganizmov. Rukovodstvo po meditsinskoy mikrobiologii. Obschaya i sanitarnaya mikrobiologiya. [Technique of inoculation, culturing and isolation of pure cultures of microorganisms. Guidelines on medical microbiology. General and sanitary microbiology]. Moscow, Binom Publ., 2008, pp. 266-280.

6. Labinskaya А.S., Eschina А.S. Biologicheskie i biokhimicheskie testy identifikatsii mikroorganizmov. Rukovodstvo po meditsinskoy mikrobiologii. Obschaya i sanitarnaya mikrobiologiya. [Biological and biochemical tests foridentification of microorganisms. Guidelines on medical microbiology. General and sanitary microbiology]. Moscow, Binom Publ., 2008, pp. 281-308.

7. Metodicheskie ukazaniya. 4.2. Metody kontrolya. Biologicheskie i mikrobiologicheskie faktory. Tekhnika sbora i transportirovaniya biomaterialov v mikrobiologicheskie laboratorii. [Guidelines. 4.2. Supervision techniques. Biological and microbiological factors. Technique for biomaterials collection and transportation to microbiological laboratories]. MU 4.2.2039 – 05

8. Mitrokhin S.D. Ratsionalnaya antimikrobnaya farmakoterapiya. Rukovodstvo dlya praktikuyuschikh vrachey 2-e izdanie, pererabotannoe i dopolnennoe. [Rational anti-microbial pharmacotherapy. Guidelines for practical doctors, 2nd edition, reviewed and supplemented]. Moscow, Litterra Publ., 2015, pp. 50-56.

9. Edict no. 109 by RF MoH as of 21.03.2003 On Improvement of TB Control Measures in the Russian Federation. (Epub. in Russ.) Available at: http://docs.cntd.ru/document/901868614

10. Edict no. 535 by USSR MoH as of 22.04.85 On Unification of Microbiological (Bacteriological) Testing Techniques Used in Clinical Diagnostic Laboratories of Medical Units. (Epub. in Russ.) Available at: http://www.libussr.ru/doc_ussr/usr_12667.htm

11. Trakhtenberg А.Kh., Chissov V.I. Statistika (zabolevaemost, smertnost, epidemiologiya). Rak legkogo. [Statistics (incidence, mortality, epidemiology). Lung cancer]. Moscow, GEOTAR-Media Publ., 2009, pp. 13-19.

12. Abidoye O., Ferguson M.K., Salgia R. Lung carcinoma in African Americans. Nat. Clin. Pract. Oncol., 2007, no. 4, pp. 118-129.

13. Akinosoglou K.S., Karkoulias K., Marangos M. Infectious complications in patients with lung cancer. Department of Internal Medicine, Department of Pulmonology and Department ofInfectious Diseases, University General Hospital of Patras, Rio, Patras, Greece. European Review for Medical and Pharmacological Sciences, 2013, no. 17, pp. 8-18.

14. Bordignon V., Bultrini S., Prignano G. et al. High prevalence of latent tuberculosis infection in autoimmune disor- ders such as psoriasis and in chronic respiratory diseases, including lung cancer. J. Biol. Regul. Homeost.Agents, 2011, vol. 25, pp. 213-220.

15. Davis A.L. Bronchogenic carcinoma in chronic obstructive pulmonary disease. JAMA, 1976, vol. 235, pp. 621-622.

16. Duque J.L., Ramos G., Castrodeza J. Early complications in surgical treatment of lung cancer: a prospective multicenter study. Ann. Thoracic. Surg., 1997, vol. 63, pp. 944-950.

17. Hoffken G., Niederman M.S. Nosocomial pneumonia: the importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest, 2002, vol. 122, no. 6, pp. 2183-2196.

18. Kohno S., Koga H., Oka M. et al. The pattern ofrespiratory infection in patients with lung cancer. Tohoku J. Exp. Med., 1994, vol. 173, no. 4, pp. 405-411.

19. Kourbeti I.S., Maslow M.J. Nontuberculous mycobacterial infections ofthe lung. Curr. Infect. Dis. Rep., 2000, vol. 2, no. 3, pp. 193-200.

20. Mitás L., Horváth T., Sobotka M. et al. Complications in patients undergoing pulmonary oncological surgery. Rozhl Chir., 2010, vol. 89, no. 2, pp. 113-117.

21. Miyamoto J., Koga H., Kohno S. et al. Clinical investigation of obstructive pneumonia with lung cancer. Kansenshogaku Zasshi, 1994, vol. 68, no. 6, pp. 728-733.

22. Perlin E., Bang K., Shah A. et al. The impact of pulmonary infections on the survival of lung cancer patients. Cancer, 1990, vol. 66, pp. 593-596.

23. Punturieri A., Szabo E., Croxton T. L. et al. Lung cancer and chronic obstructive pulmonary disease: needs and opportunities forintegrated research. J. Natl. Cancer. Inst., 2009, vol. 101, pp. 554-559.

24. Radu M., Jaureguy F., Seguin A. et al. Postoperative pneumonia after major pulmonary resections: an unsolved problem in thoracic surgery. Ann. Thorac. Surg., 2007, vol. 84, pp. 1669-1673.

25. Yao H., Rahman I. Current concepts on the role of inflammation in COPD and lung cancer. Curr. Opin. Pharmacol., 2009, vol. 9, pp. 375-383.

26. Young R.P., Hopkins R.J., Christmas T. et al. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history. Eur. Respir. J., 2009, vol. 34, pp. 380-386.